Gastric
& Breast Cancer
DOI: 10.2122/gbc.2004.0034
PRACTICE
POINT
Does neoadjuvant versus adjuvant systemic treatment improve outcomes in breast cancer?
Abstract
Adjuvant systemic therapy has traditionally been administered postoperatively, but preoperative (neoadjuvant) therapy is being increasingly utilized. 1 Neoadjuvant therapy has been recommended as standard care for patients with locally advanced breast cancer, although its role for operable breast cancer has not yet been clarified. |